دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke
Wenjie Zi, MD1; Zhongming Qiu, MD1,2; Fengli Li, MD1; Hongfei Sang, MD1,3; Deping Wu, MD1,4; Weidong Luo, MD1; Shuai Liu, MD1; Junjie Yuan, MD1; Jiaxing Song, MD1; Zhonghua Shi, MD5; Wenguo Huang, MD6; Min Zhang, MS6; Wenhua Liu, MD7; Zhangbao Guo, MS7; Tao Qiu, MD8; Qiang Shi, MS8; Peiyang Zhou, MD9; Li Wang, MD10; Xinmin Fu, MD11; Shudong Liu, MD12; Shiquan Yang, MD13; Shuai Zhang, MD14; Zhiming Zhou, MD15; Xianjun Huang, MD15; Yan Wang, MD16; Jun Luo, MS17; Yongjie Bai, MD18; Min Zhang, MS19; Youlin Wu, MS20; Guoyong Zeng, MD21; Yue Wan, MD22; Changming Wen, MD23; Hongbin Wen, MD24; Wentong Ling, MS25; Zhuo Chen, MS26; Miao Peng, MS27; Zhibing Ai, MD28; Fuqiang Guo, MD29; Huagang Li, MD30; Jing Guo, MS31; Haitao Guan, MD32; Zhiyi Wang, MS33; Yong Liu, MS34; Jie Pu, MD35; Zhen Wang, MD36; Hansheng Liu, MD1; Luming Chen, MD1; Jiacheng Huang, MD1; Guoqiang Yang, MD1; Zili Gong, MD1; Jie Shuai, MD1; Raul G. Nogueira, MD37; Qingwu Yang, MD, PhD1; for the DEVT Trial Investigators
doi : 10.1001/jama.2020.23523
JAMA. 2021;325(3):234-243
For patients with large vessel occlusion strokes, it is unknown whether endovascular treatment alone compared with intravenous thrombolysis plus endovascular treatment (standard treatment) can achieve similar functional outcomes.
Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke
Kentaro Suzuki, MD, PhD1; Yuji Matsumaru, MD, PhD2; Masataka Takeuchi, MD3; Masafumi Morimoto, MD, PhD4; Ryuzaburo Kanazawa, MD, PhD5; Yohei Takayama, MD6; Yuki Kamiya, MD, PhD7; Keigo Shigeta, MD, PhD8; Seiji Okubo, MD, PhD9; Mikito Hayakawa, MD2; Norihiro Ishii, MD, PhD10; Yorio Koguchi, MD, PhD11; Tomoji Takigawa, MD, PhD12; Masato Inoue, MD, PhD13; Hiromichi Naito, MD14; Takahiro Ota, MD, PhD15; Teruyuki Hirano, MD, PhD16; Noriyuki Kato, MD, PhD17; Toshihiro Ueda, MD, PhD18; Yasuyuki Iguchi, MD, PhD19; Kazunori Akaji, MD, PhD20; Wataro Tsuruta, MD, PhD21; Kazunori Miki, MD, PhD22; Shigeru Fujimoto, MD, PhD23; Tetsuhiro Higashida, MD, PhD5; Mitsuhiro Iwasaki, MD4; Junya Aoki, MD, PhD1; Yasuhiro Nishiyama, MD, PhD1; Toshiaki Otsuka, MD, PhD24; Kazumi Kimura, MD, PhD1; for the SKIP Study Investigators
doi : 10.1001/jama.2020.23522
JAMA. 2021;325(3):244-253
Whether intravenous thrombolysis is needed in combination with mechanical thrombectomy in patients with acute large vessel occlusion stroke is unclear.
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19
Renato D. Lopes, MD, PhD1,2,3,4; Ariane V. S. Macedo, MD, MSc1,5,6; Pedro G. M. de Barros E Silva, MD, PhD3; Renata J. Moll-Bernardes, MD, PhD1; Tiago M. dos Santos, MSc3,7; Lilian Mazza, RT3; André Feldman, MD, PhD1,8; Guilherme D’Andréa Saba Arruda, MD1,9; Den?lson C. de Albuquerque, MD, PhD1,10; Angelina S. Camiletti, RN, MSc1,4; Andréa S. de Sousa, MD, PhD1,11,12; Thiago C. de Paula, MD5; Karla G. D. Giusti, MD13; Rafael A. M. Domiciano, MD8; M?rcia M. Noya-Rabelo, MD, MHS, PhD14,15; Alan M. Hamilton, MD14; Vitor A. Loures, MD8; Rodrigo M. Dion?sio, MD16; Thyago A. B. Furquim, MD16; F?bio A. De Luca, MD, MBA, PhD17; ?talo B. dos Santos Sousa, MD17; Bruno S. Bandeira, MD18; Cleverson N. Zukowski, MD, PhD19; Ricardo G. G. de Oliveira, MD20; Noara B. Ribeiro, MD21; Jeffer L. de Moraes, MD22; Jo?o L. F. Petriz, MD, MHS, PhD23; Adriana M. Pimentel, MD, PhD24; Jacqueline S. Miranda, MD25; B?rbara E. de Jesus Abufaiad, MD26; C. Michael Gibson, MD27; Christopher B. Granger, MD2; John H. Alexander, MD, MHS2; Olga F. de Souza, MD, PhD1,4,25; for the BRACE CORONA Investigators
doi : 10.1001/jama.2020.25864
JAMA. 2021;325(3):254-264
It is unknown whether angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) have a positive, neutral, or negative effect on clinical outcomes in patients with coronavirus disease 2019 (COVID-19).
Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System
John P. Donnelly, PhD1; Xiao Qing Wang, MPH2; Theodore J. Iwashyna, MD, PhD3; Hallie C. Prescott, MD, MSc3
doi : 10.1001/jama.2020.21465
JAMA. 2021;325(3):304-306
Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons
US Preventive Services Task Force
doi : 10.1001/jama.2020.25019
JAMA. 2021;325(3):265-279
Tobacco use is the leading preventable cause of disease, disability, and death in the US. In 2014, it was estimated that 480?000 deaths annually are attributed to cigarette smoking, including second hand smoke exposure. Smoking during pregnancy can increase the risk of numerous adverse pregnancy outcomes (eg, miscarriage and congenital anomalies) and complications in the offspring (including sudden infant death syndrome and impaired lung function in childhood). In 2019, an estimated 50.6 million US adults (20.8% of the adult population) used tobacco; 14.0% of the US adult population currently smoked cigarettes and 4.5% of the adult population used electronic cigarettes (e-cigarettes). Among pregnant US women who gave birth in 2016, 7.2% reported smoking cigarettes while pregnant.
Interventions for Tobacco Cessation in Adults, Including Pregnant Persons
Carrie D. Patnode, PhD, MPH1; Jillian T. Henderson, PhD, MPH1; Erin L. Coppola, MPH1; Joy Melnikow, MD, MPH2; Shauna Durbin, MPH2; Rachel G. Thomas, MPH1
doi : 10.1001/jama.2020.23541
JAMA. 2021;325(3):280-298
It has been estimated that in 2018 nearly 20% of adults in the US were currently using a tobacco product.
The Language of Health Care Reform
Larry Levitt, MPP1
doi : 10.1001/jama.2020.25717
JAMA. 2021;325(3):215-216
Executive Action to Expand Health Services in the Biden Administration
Timothy M. Westmoreland, JD1; M. Gregg Bloche, MD, JD1; Lawrence O. Gostin, JD2
doi : 10.1001/jama.2020.25888
JAMA. 2021;325(3):217-218
The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials
Annette Rid, MD1; Marc Lipsitch, DPhil2; Franklin G. Miller, PhD3
doi : 10.1001/jama.2020.25053
JAMA. 2021;325(3):219-220
Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines
Steven Joffe, MD, MPH1
doi : 10.1001/jama.2020.25127
JAMA. 2021;325(3):221-222
Public Health Messaging in an Era of Social Media
Raina M. Merchant, MD, MSHP1,2; Eugenia C. South, MD, MSHP1,3; Nicole Lurie, MD, MSPH4,5
doi : 10.1001/jama.2020.24514
JAMA. 2021;325(3):223-224
Health Care Is a Right, Not a Privilege
Howard Bauchner, MD1; Phil B. Fontanarosa, MD, MBA2; Karen Joynt Maddox, MD, MPH3,4
doi : 10.1001/jama.2020.23915
JAMA. 2021;325(3):227-228
Intravenous Thrombolysis Before Endovascular Thrombectomy for Acute Ischemic Stroke
Jeffrey L. Saver, MD1,2; Opeolu Adeoye, MD, MS3
doi : 10.1001/jama.2020.22388
JAMA. 2021;325(3):229-231
A Comprehensive Approach to Increase Adult Tobacco Cessation
Brenna VanFrank, MD, MSPH1; Letitia Presley-Cantrell, PhD1
doi : 10.1001/jama.2020.23608
JAMA. 2021;325(3):232-233
Safe Central Venous Access in an Overburdened Health System
Karen Woo, MD, MS1; David Rigberg, MD1; Peter F. Lawrence, MD1
doi : 10.1001/jama.2020.20361
JAMA. 2021;325(3):299-300
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults
Atul Jain, MD, MS1; Andrew M. Davis, MD, MPH2
doi : 10.1001/jama.2020.24790
JAMA. 2021;325(3):301-302
COVID-19 Conspiracies and Beyond: How Physicians Can Deal With Patients’ Misinformation
Jennifer Abbasi
doi : 10.1001/jama.2020.22018
JAMA. 2021;325(3):208-210
New Guidance for Type 1 Diabetes Continuous Glucose Monitoring Use During Exercise
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.22890
JAMA. 2021;325(3):211-212
First Drug Approved for Rare Genetic Disorder Affecting Kidneys
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.26382
JAMA. 2021;325(3):214
Avoid Masks With Metal During Magnetic Resonance Imaging
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.25687
JAMA. 2021;325(3):214
Imaging Drug for Prostate Cancer
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.26384
JAMA. 2021;325(3):214
WHO Launches Global Push to Eliminate Cervical Cancer
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.25668
JAMA. 2021;325(3):213
Monthly Malaria Prophylaxis Cuts Child Deaths in Sub-Saharan Africa
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.26584
JAMA. 2021;325(3):213
Drop in Vaccination Causes Surge in Global Measles Cases, Deaths
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.26586
JAMA. 2021;325(3):213
Spraying Cotton in Bolivar County, Mississippi, the Summer Following My First Year of Medical School
Doug Hester, MD1
doi : 10.1001/jama.2020.20959
JAMA. 2021;325(3):310
Interventions to Promote Tobacco Cessation
Jill Jin, MD, MPH1
doi : 10.1001/jama.2020.25605
JAMA. 2021;325(3):316
Effect of Tidal Volume on Pulmonary Outcomes After Surgery
Chunmei Zhao, MD1; Yuesong Pan, PhD2; Fang Luo, MD1
doi : 10.1001/jama.2020.22627
JAMA. 2021;325(3):306
Effect of Tidal Volume on Pulmonary Outcomes After Surgery
Maximilian S. Schaefer, MD1; Daniel Talmor, MD1; Elias N. Baedorf-Kassis, MD2
doi : 10.1001/jama.2020.22633
JAMA. 2021;325(3):306-307
Effect of Tidal Volume on Pulmonary Outcomes After Surgery
Varun Suresh, MD, DM1
doi : 10.1001/jama.2020.22630
JAMA. 2021;325(3):307
Effect of Tidal Volume on Pulmonary Outcomes After Surgery—Reply
Dharshi Karalapillai, MD1; Ary Serpa Neto, MD, PhD2; Rinaldo Bellomo, MD3
doi : 10.1001/jama.2020.22636
JAMA. 2021;325(3):307-308
Physician Performance in the Medicare Merit-based Incentive Payment System
Vinay K. Rathi, MD, MBA1
doi : 10.1001/jama.2020.22800
JAMA. 2021;325(3):308
Physician Performance in the Medicare Merit-based Incentive Payment System—Reply
Kenton J. Johnston, PhD1; Jason M. Hockenberry, PhD2; Karen E. Joynt Maddox, MD, MPH3,4
doi : 10.1001/jama.2020.22810
JAMA. 2021;325(3):309
